Abstract PS7-23: Neoadjuvant and adjuvant therapy (NAT/AT) treatment patterns and clinical characteristics in a real-world cohort of US patients with HR+/HER2− early breast cancer (eBC)
Year: 2021
Type: conference-abstract
Source: Cancer Research
Institutions: Genentech, F. Hoffmann-La Roche AG
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W3130036614
